Penn Medicine Provider
Cardiology
Juan M. Ortega-Legaspi, MD, PhD
4.9
(240)
Accepting new patients
Sees patients age 18 and up
Penn Heart and Vascular Center
View 1 additional location

About me

  • Assistant Professor of Clinical Medicine (Cardiovascular Medicine)

Education and training

  • Medical School: Universidad Nacional Autonoma de Mexico
  • Residency: Emory University
  • Fellowship: University of Washington Hospital and Clinics
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
4.9

240 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
a great doctor
April 2025
5.0
5.0
great cardiologist!
April 2025
5.0
5.0
he just took care of me from the beginning to till now. great doctor
March 2025
5.0
5.0
he explains everything to me

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Ortega-Legaspi is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Andrew M Freddo 1, Humera Ahmed 2, Jonathan B Edelson 2, Juan M Ortega-Legaspi 3, Sumeet Vaikunth 2 3 Safety and Efficacy of GLP-1 Agonists in a Cohort of Patients with Fontan Circulation , Pediatr Cardiol .: 2024


James W Schurr 1, Adrian Pearson 1, Matthew S Delfiner 1, Alyson Brown 1, Mary Frances Quinn 2, Yoav Karpenshif 1, Juan Ortega-Legaspi 1, Aditya Parikh 1, Marisa Cevasco 3, Joyce W Wald 1 Hemodynamic Support With the Impella 5.5 Acute Mechanical Circulatory Support Device , ASAIO J: 2024


Vaikunth SS, Ortega-Legaspi JM, Conrad DR, Chen S, Daugherty T, Haeffele CL, Teuteberg J, Mclean R, MacArthur JW, Woo YJ, Maeda K, Ma M, Nasirov T, Hoteit M, Hilscher MB, Wald J, Mandelbaum T, Olthoff KM, Abt PL, Atluri P, Cevasco M, Mavroudis CD, Fuller S, Lui GK, Kim YY Mortality and morbidity after combined heart and liver transplantation in the failing Fontan: An updated dual center retrospective study , Clin Transplant, 38(4): 2024,e15302


Shingina A, Bansal N, Cedars A, Chen S, Daugherty T, Emamaullee J, Ganger D, Ge J, Heller T, Hughes D, Kay J, Ortega Legaspi J, Menachem J, Montenovo M, Sack J, Reardon L, Schiano T, Simpson K, Teuteberg J, Tompkins R, Vodkin I, Wu F, Lui G, Zaidi AN, Kappus M, Hilscher M. Combined heart liver transplantation in the patients with advanced liver disease and/or hepatocellular carcinoma: Why cannot liver pull the heart? , Am J Transplant, 24(3): 2024,503-505.


Lerman JB, Green CL, Molina MR, Maharaj V, Ortega-Legaspi JM, Sen S, Flattery M, Maziarz EK, Shah KB, Martin CM, Alexy T, Shah P, Morris AA, DeVore AD, Cole RT Multicenter study of universal prophylaxis versus pre-emptive therapy for patients at intermediate risk (R+) for CMV following heart transplantation , Clin Transplant, 37(10): 2023,e15065


Vaikunth S, Sundaravel S, Saef J, Ortega-Legaspi J Novel Therapeutic Strategies in Heart Failure in Adult Congenital Heart Disease: of Medicines and Devices , Curr Heart Fail Rep, 20(5): 2023,401-416


Durgin JS, Jariwala NN, Rook AH, Ortega-Legaspi JM. Reversible Cardiomyopathy after Interferon-Gamma for Cutaneous T Cell Lymphoma: A Report of Two Cases. , Current Problems in Cancer: Case Reports, 11: 2023


Saef J, Sundaravel S, Ortega-Legaspi J, Vaikunth S Safety and Treatment Experience with Sodium/glucose Cotransporter-2 Inhibitors (SGLT2i) in Adult Patients with Congenital Heart Disease , J Card Fail, 29(6): 2023,974-975


Ortega-Legaspi JM, Molina M, Leon J, Cunningham A, Guerraty M, Peyster E, Julien H, McLean R, Goldberg L, Bravo PE Coronary Flow Reserve is an Independent Predictor of Major Adverse Cardiovascular Events in Long Term Heart Transplantation Survivors , The Journal of Heart and Lung Transplantation: 2023


Juan M Ortega-Legaspi Miocardiopatias , Cardiologia para medicos no especialistas: 2023